Physician profile
Robert J Joseph
NPI 1891876520
$33,018.71
in general payments reported to CMS, 2019-2025
50 companies · $2,522 in 2025
The $2,522 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,016 · 2020: $2,320 · 2021: $10K · 2022: $4,413 · 2023: $7,024 · 2024: $3,324 · 2025: $2,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,262 · Consulting Fee: $3,150 · Travel and Lodging: $1,445 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,262.19 |
| Consulting Fee | $3,150.00 |
| Travel and Lodging | $1,445.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $9,416.69 | 2021-2023 | Tactoset, Fna Products, X-Twist |
| Gramercy Extremity Orthopedics LLC | $8,800.94 | 2020-2021 | |
| Viiv Healthcare Company | $4,277.93 | 2019-2025 | Dovato, Cabenuva, Apretude |
| Arthrosurface Incorporated | $2,456.24 | 2019-2020 | |
| Trimed, INC. | $1,340.12 | 2023 | |
| Stryker Corporation | $1,313.71 | 2024-2025 | Citrefix, Prostep Mica, Prophecy |
| Linvatec Corporation | $1,055.17 | 2024-2025 | Biobrace 23mm, Quantum, 5ms |
| Emd Serono, INC. | $637.27 | 2020-2025 | |
| Treace Medical Concepts, INC. | $390.84 | 2024 | |
| Trilliant Surgical LLC. | $362.74 | 2024 | 3s Hemi Implant, Large, Non-Sterile, Minimally Invasive Bunion Plate, Left, Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Janssen Biotech, INC. | $322.97 | 2019-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $287.76 | 2019-2024 | Pifeltro, Delstrigo, Dificid |
| Paratek Pharmaceuticals, INC. | $262.11 | 2022-2025 | Nuzyra |
| Novo Nordisk INC | $228.93 | 2019-2022 | |
| Abbott Laboratories | $164.31 | 2023 | Eterna, Proclaim |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$150,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.